These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 17576362

  • 1. The role of the secretory immune response in the infection by Entamoeba histolytica.
    Carrero JC, Cervantes-Rebolledo C, Aguilar-Díaz H, Díaz-Gallardo MY, Laclette JP, Morales-Montor J.
    Parasite Immunol; 2007 Jul; 29(7):331-8. PubMed ID: 17576362
    [Abstract] [Full Text] [Related]

  • 2. Role of mucosal secretory immunity in the development of an amebiasis vaccine.
    Ravdin JI, Kelsall BL.
    Am J Trop Med Hyg; 1994 Jul; 50(5 Suppl):36-41. PubMed ID: 8203722
    [Abstract] [Full Text] [Related]

  • 3. Protection against murine intestinal amoebiasis induced by oral immunization with the 29 kDa antigen of Entamoeba histolytica and cholera toxin.
    Carrero JC, Contreras-Rojas A, Sánchez-Hernández B, Petrosyan P, Bobes RJ, Ortiz-Ortiz L, Laclette JP.
    Exp Parasitol; 2010 Nov; 126(3):359-65. PubMed ID: 20303954
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Entamoeba histolytica proteolytic activity by human salivary IgA antibodies.
    Guerrero-Manríquez GG, Sánchez-Ibarra F, Avila EE.
    APMIS; 1998 Nov; 106(11):1088-94. PubMed ID: 9890272
    [Abstract] [Full Text] [Related]

  • 5. Recognition of Entamoeba histolytica 115-kDa surface protein by human secretory immunoglobulin A antibodies from asymptomatic carriers.
    Barbosa-Sabanero G, Avila EE.
    J Parasitol; 2004 Apr; 90(2):373-8. PubMed ID: 15165062
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo interaction of Entamoeba histolytica Gal/GalNAc lectin with various target cells: an immunocytochemical analysis.
    Pacheco J, Shibayama M, Campos R, Beck DL, Houpt E, Petri WA, Tsutsumi V.
    Parasitol Int; 2004 Mar; 53(1):35-47. PubMed ID: 14984834
    [Abstract] [Full Text] [Related]

  • 7. Mucosal immunity to asymptomatic Entamoeba histolytica and Entamoeba dispar infection is associated with a peak intestinal anti-lectin immunoglobulin A antibody response.
    Abd-Alla MD, Jackson TF, Rogers T, Reddy S, Ravdin JI.
    Infect Immun; 2006 Jul; 74(7):3897-903. PubMed ID: 16790762
    [Abstract] [Full Text] [Related]

  • 8. Protective immunity to amebiasis: new insights and new challenges.
    Stanley SL.
    J Infect Dis; 2001 Aug 15; 184(4):504-6. PubMed ID: 11471109
    [Abstract] [Full Text] [Related]

  • 9. Secretory immunoglobulin A antibodies to the galactose-inhibitable adherence protein in the saliva of patients with amebic liver disease.
    Kelsall BL, Jackson TG, Gathiram V, Salig SB, Vaithilingum M, Pearson RD, Ravdin JI.
    Am J Trop Med Hyg; 1994 Oct 15; 51(4):454-9. PubMed ID: 7943572
    [Abstract] [Full Text] [Related]

  • 10. Local and systemic antibody response in Balb/c mice immunized with Entamoeba histolytica trophozoites.
    Villareall BB, Melendro EI, Ramos F, Ximénez C.
    Arch Med Res; 1992 Oct 15; 23(1):69-72. PubMed ID: 1308795
    [Abstract] [Full Text] [Related]

  • 11. Distribution of Entamoeba histolytica Gal/GalNAc lectin-specific antibody response in an endemic area.
    Kaur U, Sharma AK, Sharma M, Vohra H.
    Scand J Immunol; 2004 Nov 15; 60(5):524-8. PubMed ID: 15541046
    [Abstract] [Full Text] [Related]

  • 12. Enhanced pro-inflammatory chemokine/cytokine response triggered by pathogenic Entamoeba histolytica : basis of invasive disease.
    Sharma M, Vohra H, Bhasin D.
    Parasitology; 2005 Dec 15; 131(Pt 6):783-96. PubMed ID: 16336732
    [Abstract] [Full Text] [Related]

  • 13. Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine.
    Abd Alla MD, White GL, Rogers TB, Cary ME, Carey DW, Ravdin JI.
    Infect Immun; 2007 Aug 15; 75(8):3812-22. PubMed ID: 17526742
    [Abstract] [Full Text] [Related]

  • 14. Intestinal antilectin immunoglobulin A antibody response and immunity to Entamoeba dispar infection following cure of amebic liver abscess.
    Ravdin JI, Abd-Alla MD, Welles SL, Reddy S, Jackson TF.
    Infect Immun; 2003 Dec 15; 71(12):6899-905. PubMed ID: 14638778
    [Abstract] [Full Text] [Related]

  • 15. Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica.
    Ravdin JI, Shain DC, Kelsall BL.
    Vaccine; 1993 Dec 15; 11(2):241-6. PubMed ID: 8438621
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Degradation of human secretory IgA1 and IgA2 by Entamoeba histolytica surface-associated proteolytic activity.
    Garcia-Nieto RM, Rico-Mata R, Arias-Negrete S, Avila EE.
    Parasitol Int; 2008 Dec 15; 57(4):417-23. PubMed ID: 18571975
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of adhesion process mediated by anti-Entamoeba histolytica specific monoclonal IgA antibodies.
    Leyva O, Rico G, Ramos F, Morán P, Melendro EI, Ximénez C.
    Arch Med Res; 1992 Dec 15; 23(2):227-9. PubMed ID: 1340300
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.
    Min X, Feng M, Guan Y, Man S, Fu Y, Cheng X, Tachibana H.
    PLoS Negl Trop Dis; 2016 Jan 15; 10(1):e0004419. PubMed ID: 26824828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.